1. Home
  2. KMDA vs GILT Comparison

KMDA vs GILT Comparison

Compare KMDA & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • GILT
  • Stock Information
  • Founded
  • KMDA 1990
  • GILT 1987
  • Country
  • KMDA Israel
  • GILT Israel
  • Employees
  • KMDA N/A
  • GILT N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • GILT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • KMDA Health Care
  • GILT Technology
  • Exchange
  • KMDA Nasdaq
  • GILT Nasdaq
  • Market Cap
  • KMDA 430.1M
  • GILT 429.7M
  • IPO Year
  • KMDA N/A
  • GILT 1993
  • Fundamental
  • Price
  • KMDA $7.35
  • GILT $8.80
  • Analyst Decision
  • KMDA Strong Buy
  • GILT Strong Buy
  • Analyst Count
  • KMDA 2
  • GILT 2
  • Target Price
  • KMDA $13.00
  • GILT $11.00
  • AVG Volume (30 Days)
  • KMDA 49.4K
  • GILT 698.1K
  • Earning Date
  • KMDA 08-13-2025
  • GILT 08-06-2025
  • Dividend Yield
  • KMDA 2.72%
  • GILT N/A
  • EPS Growth
  • KMDA 27.97
  • GILT 12.49
  • EPS
  • KMDA 0.32
  • GILT 0.39
  • Revenue
  • KMDA $169,517,000.00
  • GILT $349,746,000.00
  • Revenue This Year
  • KMDA $14.51
  • GILT $42.88
  • Revenue Next Year
  • KMDA $9.31
  • GILT $13.26
  • P/E Ratio
  • KMDA $22.26
  • GILT $22.52
  • Revenue Growth
  • KMDA 9.67
  • GILT 19.67
  • 52 Week Low
  • KMDA $5.17
  • GILT $4.30
  • 52 Week High
  • KMDA $9.16
  • GILT $9.40
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 48.99
  • GILT 63.94
  • Support Level
  • KMDA $7.15
  • GILT $8.74
  • Resistance Level
  • KMDA $7.85
  • GILT $9.38
  • Average True Range (ATR)
  • KMDA 0.22
  • GILT 0.35
  • MACD
  • KMDA 0.00
  • GILT 0.06
  • Stochastic Oscillator
  • KMDA 54.13
  • GILT 72.48

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

Share on Social Networks: